On July 9, Astera Labs rose 4.03% in pre-market trading, trading at $410.88/share, with turnover of $1.7906 million.

On the news front, the company announced it will hold a conference call to review its second quarter financial results, boosting market sentiment. Concurrently, the semiconductor sector continued its broader recovery, with peers Micron Technology up 4.76%, Intel up 3.73%, Advanced Micro Devices up 2.59%, and Broadcom up 1.62%.

The stock had previously fallen over 14% after multiple directors disclosed aggregate sell-off plans exceeding $170 million — including MAR 2011 Childrens Trust planning to sell 170,000 shares worth approximately $82.11 million, Director Manuel Alba planning to sell 150,000 shares worth approximately $72.45 million, and CASA ALAMEDA 2007, LLC planning to sell 33,000 shares worth approximately $15.94 million. Following the sharp pullback, capital has been flowing back at lower levels. Additionally, Bank of America Securities recently raised the company's price target to $450, and UBS raised it to $400, citing strong prospects in the data center CXL high-speed interconnect market.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)